No Data
No Data
Athira Pharma's Regulatory Compliance Challenges Threaten Drug Development Pipeline
Althira Pharma Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 EPS Results.
Express News | Althira Pharma Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 EPS Results
JMP Securities Maintains Athira(ATHA.US) With Hold Rating
Athira Pharma Reports Q3 2024 Financial Results
JMP Securities Keeps Their Hold Rating on Athira Pharma (ATHA)
browny_440 : volume